‘Need to institutionalize best practices learnt during last one and half years’: PM Modi to vaccine manufacturers
The entire world is looking up to India, in the backdrop of the success of the vaccination drive
Interacting with domestic vaccine manufactures on Saturday, Prime Minister Narendra Modi exhorted that the country needs to institutionalise the best practises learnt during the last one and a half years. He asked vaccine manufacturers that this is an opportunity to modify their practises in tune with the global standards.
PM Modi praised vaccine manufacturers for helping the country in crossing the milestone of 100 crore vaccinations. He appreciated their hard work and confidence given by them during the pandemic.
The Prime Minister stated that the entire world is looking up to India, in the backdrop of the success of the vaccination drive. He also said that the vaccine manufacturers should continuously work together to be ready to face future challenges.
The domestic vaccine manufacturers appreciated the vision and dynamic leadership of the Prime Minister in providing continuous guidance and support towards the development of the vaccines.
They also praised the never before seen collaboration between government and industry, and applauded the regulatory reforms, simplified procedures, timely approvals, and forthcoming and supportive nature of the government throughout this endeavour.
Indigenous vaccine manufacturers noted that had the country been following old norms, there would have been considerable delay and we would not have been able to reach the vaccination level that we have attained till now.
Serum Institute of India CEO, Adar Poonawala praised the regulatory reforms brought out by the government. Cyrus Poonawalla, the Chairman and MD of Serum Institute of India and praised the leadership of the Prime Minister throughout the course of the pandemic.
Krishna Ella, Chairman and MD of Bharat Biotech International Ltd, thanked the Prime Minister for having taken Covaxin, and for the continuous support and motivation during its development.
Zydus Cadila owner, Pankaj Patel thanked the PM Modi for talking about the DNA based vaccine in the UN General Assembly.
Mahima Datla, MD and promoter Biological E. Ltd commended the vision of the Prime Minister which helped the country attain the vaccination milestone.
Gennova Biopharmaceuticals Ltd CEO, Sanjay Singh talked about the importance of innovation and backward integration in the field of vaccine development.
Satish Reddy, Chairman of Dr. Reddy's Lab appreciated the collaboration between government and industry throughout this endeavour.
Panacea Biotec Ltd. Managing Director, Rajesh Jain praised the continuous communication by the government throughout the pandemic.
The interaction was attended by Cyrus Poonawalla and Adar Poonawalla, Serum Institute of India; Krishna Ella and Suchitra Ella, Bharat Biotech International Ltd; Pankaj Patel and Shervil Patel, Zydus Cadila; Mahima Datla and Narender Mantela, Biological E. Ltd.
Other attendees at the interaction included Sanjay Singh and Satish Ramanlal Mehta, Gennova Biopharmaceuticals Ltd; Satish Reddy and Deepak Sapra, Dr. Reddy's Lab and Rajesh Jain and Harshit Jain, Panacea Biotec Ltd.